GreenLight Biosciences Holdings, PBC: key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022): $6.8M
Net Income/Loss (FY2022): -$167.1M
Total Assets (FY2022): $148.6M
Total Equity (FY2022): $48.1M
Cash Flows from Operating Activities (FY2022): -$136.7M

Source: GreenLight Biosciences Holdings, PBC 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

GreenLight Biosciences Holdings, PBC: key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022): $6.8M
Net Income/Loss (FY2022): -$167.1M
Total Assets (FY2022): $148.6M
Total Equity (FY2022): $48.1M
Cash Flows from Operating Activities (FY2022): -$136.7M

Source: GreenLight Biosciences Holdings, PBC 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.